Claudia Teo
Independent Director
Healthcare
iX Biopharma
Singapore
Biography
Claudia Teo was appointed to the Board on 18 June 2015 and serves as Chairman of the Nominating Committee and a member of the Audit and Remuneration Committees. Claudia currently heads the Corporate and Financial Services practice group in Harry Elias Partnership LLP (“HEPâ€). She possesses over 20 years of experience in advising on landmark transactions in corporate finance, including initial public offerings on the SGX-ST, placements and rights issues, privatisations, compliance and corporate governance issues.Â
Research Interest
Healthcare